Cargando…

P1292: BASILIXIMAB MAY BE THE POTENTIAL SOLUTION FOR SEVERE LIVER CHRONIC GRAFT-VERSUS-HOST DISEASE: A PROSPECTIVE PILOT STUDY

Detalles Bibliográficos
Autores principales:	Deng, Dao-Xing, Shen, Meng-Zhu, Zhang, Xiao-Hui, Xu, Lanping, Wang, Yu, Yan, Chen-Hua, Chen, Yu-Hong, Chen, Huan, Han, Wei, Wang, Feng-Rong, Wang, Jing-Zhi, Huang, Xiao-Jun, Mo, Xiao-Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430603/ http://dx.doi.org/10.1097/01.HS9.0000972056.91461.24

Ejemplares similares

Immune Reconstitution of Patients Who Recovered From Steroid-Refractory Acute Graft-Versus-Host Disease After Basiliximab Treatment
por: Deng, Dao-Xing, et al.
Publicado: (2022)

PReS13-SPK-1292: Gut microbiome and metabolism
por: Tilg, H
Publicado: (2013)

Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial
por: Zhao, Ke, et al.
Publicado: (2022)

Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant
por: Yan, Chen-Hua, et al.
Publicado: (2016)

Basiliximab for the therapy of acute T cell–mediated rejection in kidney transplant recipient with BK virus infection: A case report
por: Chen, Tingting, et al.
Publicado: (2022)

The role of basiliximab in the evolving renal transplantation immunosuppression protocol
por: Salis, Paola, et al.
Publicado: (2008)

Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant
por: Yan, Chen-Hua, et al.
Publicado: (2019)

Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation
por: Shen, Meng-Zhu, et al.
Publicado: (2022)

A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation
por: Shen, Meng-Zhu, et al.
Publicado: (2022)

Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation
por: López-Abente, Jacobo, et al.
Publicado: (2021)

Thermophile-specific proteins: the gene product of aq_1292 from Aquifex aeolicus is an NTPase
por: Klinger, Claudia, et al.
Publicado: (2003)

Simplification and Transformation of ASTM F1292 Measurement Procedure for Fall Accident Injury Criteria
por: KATO, Maki, et al.
Publicado: (2014)

Reduced Progression of Cardiac Allograft Vasculopathy with Routine Use of Induction Therapy with Basiliximab
por: Wang, Ricardo, et al.
Publicado: (2015)

Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation
por: Sageshima, Junichiro, et al.
Publicado: (2009)

Efficacy of basiliximab induction in poorly matched living donor renal transplantation
por: Gundlapalli, S., et al.
Publicado: (2013)

Erratum: Estimating Free and Added Sugar Intakes in New Zealand; Nutrients 2017, 9, 1292
por: Kibblewhite, Rachael, et al.
Publicado: (2018)

Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activity
por: Kluss, Jillian H., et al.
Publicado: (2018)

1292. Integrating HIV and Hepatitis C Screening in a High-Risk Emergency Department Population
por: Chechi, Tasleem, et al.
Publicado: (2019)

Monocyte subsets in bone marrow grafts may contribute to a low incidence of acute graft‐vs‐host disease for young donors
por: Wen, Qi, et al.
Publicado: (2020)

Corneal perforation associated with ocular graft-versus-host disease
por: Xu, Yue, et al.
Publicado: (2022)

Basiliximab/steroids/tacrolimus: Pneumonia with Scedosporium apiospermum and Lomentospora prolificans: case report
Publicado: (2021)

Basiliximab Induction with Delayed Calcineurin Inhibitors for High-Risk Lung Transplant Candidates
por: Kim, Ha Eun, et al.
Publicado: (2021)

Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
por: Lam, Ngan N., et al.
Publicado: (2021)

The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation
por: Gao, Meng-Ge, et al.
Publicado: (2021)

P1317: TIME-DEPENDENT ANALYSIS OF THE IMPACT ON EARLY CMV REACTIVATION OF HLA MISMATCH AND ACUTE GRAFT-VERSUS-HOST-DISEASE AFTER ALLO-HSCT FROM RELATED DONORS IN ACQUIRED APLASTIC ANEMIA.
por: Lin, Fan, et al.
Publicado: (2023)

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
por: Furukawa, Masashi, et al.
Publicado: (2022)

P1292: MOLECULAR CHARACTERIZATION OF DIFFUSE LARGE B-CELL LYMPHOMA ASSOCIATED TO HEPATITIS C VIRUS INFECTION
por: Sciarra, R., et al.
Publicado: (2022)

PSEN1 c.1292C<A Variant and Early-Onset Alzheimer’s Disease: A Scoping Review
por: Orozco-Barajas, Maribel, et al.
Publicado: (2022)

Treating a GAD65 Antibody-Associated Limbic Encephalitis with Basiliximab: A Case Study
por: Widman, Guido, et al.
Publicado: (2015)

Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin
por: Jeong, Rachel, et al.
Publicado: (2020)

Thymoglobulin Versus Alemtuzumab Versus Basiliximab Kidney Transplantation From Donors After Circulatory Death
por: Asderakis, Argiris, et al.
Publicado: (2022)

1292. HIV Pre-Exposure Prophylaxis (PrEP) Implementation at Silom Community Clinic in Bangkok, Thailand, 2016–2018
por: Kung, Vanessa, et al.
Publicado: (2018)

1292P A review of in-hospital end-of-life care (EOLC) for oncology patients during the COVID-19 pandemic
por: Carroll, H.K., et al.
Publicado: (2022)

Basiliximab induction therapy in kidney transplantation: Benefits for long term allograft function after 10 years?
por: Koch, Martina, et al.
Publicado: (2009)

Comparison of Basiliximab and Anti‐Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis
por: Ansari, David, et al.
Publicado: (2015)

Basiliximab for early perioperative transplant-associated thrombotic microangiopathy after lung transplantation: a case report
por: Ijiri, Naohiro, et al.
Publicado: (2022)

Very Low Dose Anti-Thymocyte Globulins Versus Basiliximab in Non-Immunized Kidney Transplant Recipients
por: Masset, Christophe, et al.
Publicado: (2023)

Successful treatment of severe immune checkpoint inhibitor associated autoimmune hepatitis with basiliximab: a case report
por: Zarrabi, Maiah, et al.
Publicado: (2023)

1292 Incidence of norovirus-associated acute gastroenteritis in four Veteran's Affairs Medical Center populations in the United States, 2011-2012
por: Grytdal, Scott, et al.
Publicado: (2014)

1292. Evaluation of Synergy with Piperacillin/Tazobactam plus Meropenem Against Carbapenemase-Producing Klebsiella pneumoniae and Enterobacter cloacae Using ETEST
por: Ashcraft, Deborah S, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f2qnlrj2r0h3stknuel78aro7q